Diaceutics PLC
DIUXF
Get informed when a big investor buys or sells
+ FollowMarket Cap$195.16M
Close$
Share Statistics
| Market cap | $195.16 Million |
|---|---|
| Enterprise Value | $190.73 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.89 |
| Outstanding Shares | 84,674,884 |
Return
| Return on Equity | -4.62% |
|---|---|
| Return on Assets | -3.43% |
| Return on Invested Capital | -7.36% |
Valuation & Multiples
| P/E Ratio | -634.38 |
|---|---|
| PEG | -4138.95 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.52 |
| Enterprise Value to EBIT | -63.73 |
| Enterprise Value to Net Income | -107 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 22, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$23.20 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Diaceutics PLC
205 employees
CEO: Ryan Keeling Diaceutics PLC operates as a global diagnostic commercialization entity, providing pharmaceutical companies worldwide with essential data, sophisticated analytics, and implementation support. Central to its offerings is the DXRX platform...